We are live on ! Find out more
CST

Charles Schwab Trust Portfolio holdings

AUM $1.79B
1-Year Est. Return 17.47%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+17.47%
3 Year Est. Return
+45.63%
5 Year Est. Return
+40.09%
10 Year Est. Return
AUM
$616M
AUM Growth
+$107M
Cap. Flow
+$82.9M
Cap. Flow %
13.46%
Top 10 Hldgs %
60.52%
Holding
186
New
13
Increased
49
Reduced
68
Closed
16

Sector Composition

Rank Sector Weight
1 Technology 5.41%
2 Industrials 4.28%
3 Healthcare 2.99%
4 Financials 1.9%
5 Consumer Discretionary 1.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
26
Johnson & Johnson
JNJ
$640B
$4.1M 0.67%
23,991
+217
+0.9% +$35.5K
HD icon
27
Home Depot
HD
$337B
$4.03M 0.65%
9,701
+123
+1% +$46.8K
IJR icon
28
iShares Core S&P Small-Cap ETF
IJR
$109B
$3.8M 0.62%
33,180
+27,319
+466% +$3.11M
PFF icon
29
iShares Preferred and Income Securities ETF
PFF
$13.1B
$3.71M 0.6%
94,066
-5,921
-6% -$230K
NVDA icon
30
NVIDIA
NVDA
$4.6T
$3.44M 0.56%
117,040
+16,000
+16% +$440K
SPTL icon
31
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$10.5B
$3.02M 0.49%
71,600
-9,221
-11% -$387K
BKLN icon
32
Invesco Senior Loan ETF
BKLN
$6.96B
$2.99M 0.49%
135,451
-11,201
-8% -$247K
VO icon
33
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$2.83M 0.46%
44,408
PXF icon
34
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.83B
$2.64M 0.43%
55,701
-108,240
-66% -$5.15M
DE icon
35
Deere & Co
DE
$165B
$2.59M 0.42%
7,545
IEMG icon
36
iShares Core MSCI Emerging Markets ETF
IEMG
$144B
$2.53M 0.41%
42,315
-35,364
-46% -$2.18M
UNH icon
37
UnitedHealth
UNH
$382B
$2.4M 0.39%
4,778
+85
+2% +$38.5K
MA icon
38
Mastercard
MA
$498B
$2.36M 0.38%
6,570
+2,000
+44% +$692K
VCIT icon
39
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
$2.29M 0.37%
24,670
-186,459
-88% -$17.4M
MDT icon
40
Medtronic
MDT
$112B
$2.22M 0.36%
21,427
-305
-1% -$35.3K
MMM icon
41
3M
MMM
$91.8B
$2.15M 0.35%
14,480
+208
+1% +$31K
SCHP icon
42
Schwab US TIPS ETF
SCHP
$16.4B
$2.06M 0.33%
65,394
-611,732
-90% -$19.3M
IWF icon
43
iShares Russell 1000 Growth ETF
IWF
$117B
$2.02M 0.33%
26,428
ABBV icon
44
AbbVie
ABBV
$465B
$2M 0.32%
14,772
-25
-0.2% -$2.95K
PFE icon
45
Pfizer
PFE
$143B
$1.98M 0.32%
33,598
+35
+0.1% +$1.73K
PG icon
46
Procter & Gamble
PG
$340B
$1.96M 0.32%
11,989
-15
-0.1% -$2.23K
CVX icon
47
Chevron
CVX
$382B
$1.92M 0.31%
16,340
-239
-1% -$27.1K
SCHX icon
48
Schwab US Large- Cap ETF
SCHX
$70.3B
$1.89M 0.31%
99,378
-1,614,660
-94% -$29.8M
VEU icon
49
Vanguard FTSE All-World ex-US ETF
VEU
$64.8B
$1.87M 0.3%
30,455
SCHQ
50
Schwab Long-Term US Treasury ETF
SCHQ
$798M
$1.83M 0.3%
35,729
+1,144
+3% +$58.3K

Similar funds

Charles Schwab Trust's Q4 2021 Portfolio in Review

As of Q4 2021, Charles Schwab Trust held 186 positions worth $616M, up 21% from $509M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Charles Schwab Trust deployed $82.9M of net new capital in Q4 2021, opening 13 new positions and adding to 49 existing holdings. Its largest new stake was Vanguard Total Bond Market: 339,908 shares worth $28.8M.

By sector, the portfolio is most concentrated in Technology at 5.4% of assets, up from 5% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Schwab US Large- Cap ETF, an estimated $29.8M trimmed.

  • Charles Schwab Trust's largest Q4 2021 buy was Vanguard Total Bond Market: 339,908 shares worth $28.8M.
  • Charles Schwab Trust added most to iShares Core US Aggregate Bond ETF in Q4 2021, an estimated $102M increase.
  • Charles Schwab Trust's biggest Q4 2021 reduction was Schwab US Large- Cap ETF, cutting an estimated $29.8M.
  • Charles Schwab Trust fully exited Invesco FTSE RAFI US 1000 ETF in Q4 2021, selling an estimated $6.78M.
  • Charles Schwab Trust's ten largest holdings make up 61% of its $616M portfolio in Q4 2021.
  • Charles Schwab Trust opened 13 new positions and closed 16 in Q4 2021.
  • Charles Schwab Trust's portfolio value rose 21% quarter-over-quarter to $616M.

Based on Charles Schwab Trust's 13F filing for Q4 2021, filed 14 Jan 2022.